Polimorfismos en el gen promotor de IL-10 en una muestra de pacientes colombianos con lepra
Resumen
Introducción. Se han reportado polimorfismos en los genes promotores que codifican para citocinas y que afectan los niveles de transcripción, con implicaciones clínicas y funcionales en pacientes con lepra.
Objetivo. Detectar los polimorfismos en el gen promotor de la interleucina 10 (IL-10), de los polimorfismos de un solo nucleótido (Single Nucleotide Polymorphisms, SNP) -1082 A/G (rs1800896), -819C/T (rs1800871) y -592A/C (rs1800872), en 100 pacientes con lepra y un grupo control de 100 voluntarios, de una región endémica de Colombia.
Resultados. Los haplotipos -819C-519C y -1082A-819C-592C mostraron asociación significativa con lepra: OR=4,34, p=1 x 10-3, y OR=6,25, p=5 x 10-4, respectivamente. Estos haplotipos en condiciones de homocigoto, están también asociados con lepra: -819C-519C/-819C-519C (OR=4,34 p=1 x 10-3), -1082A -819C-592C/-1082A -819C-592C (OR=1,90 y p=0,04). El SNP -1082 no se encontró asociado
con lepra en esta población. Los genotipos C/C y C/T en el SNP -819, se encontraron asociados a lepra (OR=4,34, p=1 x 10-3); de igual manera, los genotipos C/C y C/A en el SNP -592 mostraron asociación (OR=4,34, p=1 x 10-3).
Conclusiones. El haplotipo que encontramos asociado con lepra, -1082A-819C-592C/-1082A-819C-592C, se ha relacionado con baja producción de IL-10. Funcionalmente, esta baja producción de IL-10 puede tener consecuencias en la respuesta inmunitaria, además de implicaciones clínicas. Se han reportado diferentes haplotipos de IL-10 como marcadores de vulnerabilidad y resistencia de lepra en otras poblaciones, lo cual sugiere que las diferencias en la distribución de diversos polimorfismos del gen de IL-10 entre grupos étnicos, es un factor importante al determinar la asociación entre enfermedad y genes.
Descargas
Referencias bibliográficas
Alter A, Alcaıs A, Abel L, Schurr E. Leprosy as a genetic model for susceptibility to common infectious diseases. Hum Genet. 2008;123:227-35.
Bayley JP, Ottenhoff TH, Verweij CL. Is there a future for TNF promoter polymorphisms? Genes Immun. 2004;5:315-29.
Eskdale J, Keijsers V, Huizinga T, Gallagher G. Microsatellite alleles and single nucleotide polymorphisms (SNP) combine to form four major haplotype families at the human interleukin-10 (IL-10) locus. Genes Immun. 1999;1:151-5.
Mörmann M, Rieth H, Hua TD, Assohou C, Roupelieva M, Hu SL, et al. Mosaics of gene variations in the interleukin-10 gene promoter affect interleukin-10 production depending on the stimulation used. Genes Immun. 2004;5:246-55.
Fife MS, Ogilvie EM, Kelberman D, Samuel J, Gutiérrez A, Humphries SE, et al. Novel IL-6 haplotypes and disease association. Genes Immun. 2005;6:367-70.
Fishman D, Faulds G, Jeffery R, Mohamed-Ali, Yudkin JS. The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest. 1998;102:1369-76.
Franceschi DS, Mazini PS, Rudnick CC, Sell AM, Tsuneto LT, Ribas ML, et al. Influence of TNF and IL10 gene polymorphisms in the immunopathogenesis of leprosy in the south of Brazil. Int J Infect Dis. 2009;13:493-8.
Hasan Z, Mahmood A, Zafar S, Khan AA, Hussain R. Leprosy patients with lepromatous disease have an upregulated IL-8 response that is unlinked to TNF-α responses. Int J Lepr Other Mycobact Dis. 2004;72:35-44.
Pravica V, Perrey C, Stevens A, Lee JH, Hutchinson IV. A single nucleotide polymorphism in the first intron of the human IFN-gamma gene: Absolute correlation with a polymorphic CA microsatellite marker of high IFN-gamma production. Hum Immunol. 2000;9:863-6.
Brinkman BM, Zuijdeest D, Kaijzel EL, Breedveld FC, Verjweij CL. Relevance of the tumor necrosis factor alpha (TNF alpha) – 308 promoter polymorphism in TNF alpha regulation. J Inflamm. 1995;46:32-41.
Schurr E, Gros P. A common genetic fingerprint in leprosy and Crohn’s disease? N Engl J Med. 2009;361:2666-8.
Blackwell JM, Black JF, Peacock CS, Miller EN, Sibthorpe D, Gnananandha D, et al. Immunogenetics of leishmanial and mycobacterial infections: The Belem family study. Philos Trans R Soc Lond B Biol Sci.1997;352:1331-45.
Cardoso CC, Pereira AC, Brito-de-Souza VN, Dias-Baptista IM, Maniero VC, Venturini J, et al. IFNG +874 T>A single nucleotide polymorphism is associated with leprosy among Brazilians. Hum Genet. 2010;128:481-90.
Moraes MO, Cardoso CC, Vanderborght PR, Pacheco AG. Genetics of host response in leprosy. Lepr Rev. 2006;77:189-202.
Stefani MM, Martelli CM, Gillis TO, Krahenbuhl JL, Brazilian Leprosy Study Group. In situ type I cytokine gene expression and mechanisms associated with early leprosy progression. J Infect Dis. 2003;188:1024-31.
Malhotra D, Darvishi K, Sood S, Sharma S, Grover Ch, Relhan V, et al. IL-10 promoter single nucleotide polymorphisms are significantly associated with resistance to leprosy. Hum Genet. 2005;118:295-300.
Franceschi D, Mazini P, Rudnick C, Sell A, Tsuneto L, Ribas M, et al. Influence of TNF and IL10 gene polymorphisms in the immunopathogenesis of leprosy in the south of Brazil. Int J Infect Dis. 2009;13:493-8.
Santos AR, Suffys PN, Vanderborght PR, Moraes MO, Vieira LM, Cabello PH, et al. Role of tumor necrosis factor-α and interleukin-10 promoter gene polymorphisms in leprosy. J Infect Dis. 2002;186:1687-91.
Moraes MO, Pacheco AG, Schonkeren JJ, Vanderborght PR, Nery JA, Santos AR, et al. Interleukin-10 promoter singlenucleotide polymorphisms as markers for disease susceptibility and disease severity in leprosy. Genes Immun. 2004;5:592-5.
Aggarwal S, Ali S, Chopra R, Srivastava A, Kalaiarasan P, Malhotra D, et al. Genetic variations and interactions in anti-inflammatory cytokine pathway genes in the outcome of leprosy: A study conducted on a MassARRAY platform. J Infect Dis. 2011;204:1264-73.
Fitness J, Tosh K, Hill AV. Genetics of susceptibility to leprosy. Genes Immnun. 2002;3:441-53.
Scollard DM, Adams LB, Gillis TP, Krahenbuhl JL, Truman RW, Williams DL. The Continuing Challenges of Leprosy. Clin Microb Rev. 2006;2:338-81.
Isenberg H, Della-Latta P, Weitzman I. Acid-fast stains. En: Isenberg H.D. Editor. Clinical microbiology procedures handbook. Second edition. Washington, D.C: American Society for Microbiology; 1992.
Ridley RS, Jopling WH. Classification of leprosy according to immunity –a five group system. Int J Lepr.1966;34:225-73.
Pardillo F, Fajardo T, Abalos R, Scollard D, Gelber R. Methods for the classification of leprosy for treatment purposes. Clin Infect Dis. 2007;44:1096-9.
Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988;16:1215.
Perrey C, Turner SJ, Pravica V, Howell WM, Hutchinson IV. ARMS-PCR methodologies to determine IL-10, TNFalpha, TNF-beta and TGF-beta 1 gene polymorphisms. Transpl Immunol. 1999;2:127-8.
Fitness J, Floyd S, Warndorff DK, Sichali L, Mwaungulu L, Crampin AC, et al. Large-scale candidate gene study of leprosy susceptibility in the Karonga district of Northern Malawi. Am J Trop Med Hyg. 2004;71:330-40.
Rojas W, Parra MV, Campo O, Caro MA, Lopera JG, Arias W, et al. Genetic make up and structure of Colombian populations by means of uniparental and biparental DNA markers. Am J Phys Anthropol. 2010;143:13-20.
Belgaumkar VA, Gokhale NR, Mahajan PM, Bhraradwaj RB, Pandit DP, Deshpande S. Circulating cytokine profiles in leprosy patients. Lepr Rev. 2007;78:223-30.
Reuss E, Fimmers R, Kruger A, Becker C, Rittner C, Hohler T. Differential regulation of interleukin-10 production by genetic and environmental factors –a twin study. Genes Immun. 2002;3:407-13.
Sinsimer D, Fallows D, Peixoto B, Krahenbuhl J, Kaplan G, Manca C. Mycobacterium leprae actively modulates the cytokine response in naive human monocytes. Infect Immun. 2010;78:293-300.
Moraes MO, Santos AR, Schonkeren JJ, Vanderborght PR, Ottenhoff TH, Moraes ME, et al. Interleukin-10 promoter haplotypes are differently distributed in the Brazilian versus the Dutch population. Immunogenetics. 2003;54:896-9.
Salhi A, Rodrigues Jr V, Santoro F, Dessein H, Romano A, Castellano LR, et al. Immunological and genetic evidence for a crucial role of IL-10 in cutaneous lesions in humans infected with Leishmania braziliensis. J Immunol. 2008;180:6139-48.
Pereira AC, Brito-de-Souza VN, Cardoso CC, Dias-Baptista IM, Parelli FP, Venturini J, et al. Genetic, epidemiological and biological analysis of interleukin-10 promoter single-nucleotide polymorphisms suggests a definitive role for -819C/T in leprosy susceptibility. Genes Immun. 2009;10:174-80.
Bleharski JR, Li H, Meinken C, Graeber TG, Ochoa MT, Yamamura M, et al. Use of genetic profiling in leprosy to discriminate clinical forms of the disease. Science. 2003;301:1527-30.
| Estadísticas de artículo | |
|---|---|
| Vistas de resúmenes | 106 |
| Vistas de PDF | 43 |
| Descargas de PDF | 36 |
| Vistas de HTML | 7 |
| Otras vistas | 0 |
